GeneDx Holdings Corp
NASDAQ:WGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GeneDx Holdings Corp
NASDAQ:WGS
|
US |
|
Learning Technologies Group PLC
LSE:LTG
|
UK |
|
Lindsay Australia Ltd
ASX:LAU
|
AU |
|
SinterCast AB
STO:SINT
|
SE |
|
C
|
China Treasures New Materials Group Ltd
HKEX:2439
|
CN |
|
G
|
Genting Singapore Ltd
OTC:GIGNY
|
SG |
Balance Sheet
Balance Sheet Decomposition
GeneDx Holdings Corp
GeneDx Holdings Corp
Balance Sheet
GeneDx Holdings Corp
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
115
|
108
|
401
|
124
|
100
|
85
|
105
|
|
| Cash Equivalents |
115
|
108
|
401
|
124
|
100
|
85
|
105
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
30
|
56
|
66
|
|
| Total Receivables |
22
|
32
|
27
|
43
|
33
|
38
|
74
|
|
| Accounts Receivables |
21
|
32
|
27
|
43
|
32
|
37
|
74
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Inventory |
16
|
25
|
34
|
14
|
9
|
11
|
14
|
|
| Other Current Assets |
11
|
9
|
23
|
32
|
11
|
9
|
9
|
|
| Total Current Assets |
164
|
174
|
484
|
213
|
182
|
198
|
268
|
|
| PP&E Net |
35
|
63
|
63
|
84
|
59
|
59
|
69
|
|
| PP&E Gross |
35
|
63
|
63
|
84
|
59
|
59
|
69
|
|
| Accumulated Depreciation |
18
|
30
|
52
|
102
|
46
|
52
|
26
|
|
| Intangible Assets |
0
|
0
|
0
|
187
|
173
|
159
|
168
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
14
|
|
| Other Long-Term Assets |
5
|
14
|
8
|
7
|
4
|
4
|
4
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
14
|
|
| Total Assets |
204
N/A
|
252
+23%
|
554
+120%
|
491
-11%
|
419
-15%
|
419
+0%
|
524
+25%
|
|
| Liabilities | ||||||||
| Accounts Payable |
18
|
27
|
45
|
48
|
10
|
8
|
8
|
|
| Accrued Liabilities |
15
|
34
|
45
|
82
|
44
|
42
|
84
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
3
|
5
|
3
|
4
|
2
|
2
|
5
|
|
| Other Current Liabilities |
5
|
8
|
9
|
11
|
3
|
3
|
12
|
|
| Total Current Liabilities |
40
|
73
|
101
|
144
|
59
|
55
|
109
|
|
| Long-Term Debt |
22
|
40
|
29
|
22
|
71
|
70
|
65
|
|
| Deferred Income Tax |
0
|
0
|
0
|
3
|
2
|
1
|
1
|
|
| Other Liabilities |
13
|
134
|
35
|
69
|
59
|
48
|
40
|
|
| Total Liabilities |
75
N/A
|
247
+228%
|
166
-33%
|
237
+43%
|
191
-20%
|
174
-9%
|
216
+24%
|
|
| Equity | ||||||||
| Common Stock |
217
|
334
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
89
|
330
|
575
|
1 124
|
1 300
|
1 352
|
1 373
|
|
| Additional Paid In Capital |
0
|
0
|
964
|
1 378
|
1 528
|
1 597
|
1 681
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Equity |
128
N/A
|
4
-97%
|
388
+8 720%
|
254
-35%
|
228
-10%
|
245
+8%
|
308
+26%
|
|
| Total Liabilities & Equity |
204
N/A
|
252
+23%
|
554
+120%
|
491
-11%
|
419
-15%
|
419
+0%
|
524
+25%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
7
|
7
|
7
|
12
|
26
|
28
|
29
|
|